T1	Participants 443 451	Patients
T2	Participants 560 656	Seventy patients with Expanded Disability Status Scale scores of 0 to 5.5 were randomly assigned
T3	Participants 752 760	Patients
T4	Participants 1208 1215	patient
T5	Participants 1609 1632	placebo treatment group
T6	Participants 1505 1533	valacyclovir treatment group
T7	Participants 1726 1754	valacyclovir treatment group
T8	Participants 1782 1805	placebo treatment group
T9	Participants 1892 1900	patients
T10	Participants 1998 2018	subgroup of patients
